Open AccessIs cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?
Author(s) -
Bogumił Ramotowski,
Andrzej Budaj
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2021.0025
Subject(s) - medicine , cytisine , interquartile range , percutaneous coronary intervention , coronary artery disease , adverse effect , conventional pci , incidence (geometry) , smoking cessation , cardiology , myocardial infarction , physics , receptor , nicotinic agonist , pathology , optics
Cytisine is contraindicated, and its effects have not been evaluated in patients with coronary artery disease (CAD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom